Candid B Cream (Clotrimazole/Beclometasone)

Product Overview

Candid B Cream is a prescription‑strength, topically applied medication developed by Glenmark Pharmaceuticals Ltd., a globally recognized manufacturer of high‑quality generic pharmaceuticals. The product is formulated as a semi‑solid emulsion that combines 1 % w/w clotrimazole, an imidazole‑derived antifungal, with 0.05 % w/w beclometasone dipropionate, a synthetic glucocorticoid with potent anti‑inflammatory potency. The cream is supplied in aluminum tubes that protect the formulation from light and moisture, ensuring stability throughout the shelf life. Pack sizes include a 10 g tube for trial use, a 20 g tube for standard therapy, and a 30 g tube for larger surface‑area treatment or chronic management. The formulation is indicated for the topical management of dermatophyte and yeast infections of the skin where both antifungal activity and reduction of accompanying inflammation are required. It is registered with the appropriate regulatory authorities and complies with current Good Manufacturing Practices (cGMP).

What is Candid B Cream?

Candid B Cream belongs to the pharmacological class of topical antifungal‑corticosteroid combinations. The active ingredient clotrimazole exerts its effect by inhibiting the fungal enzyme lanosterol 14α‑demethylase, which disrupts ergosterol biosynthesis and compromises the fungal cell membrane. Beclometasone dipropionate, once absorbed into the skin, undergoes enzymatic conversion to its active metabolite, beclometasone, which binds to the glucocorticoid receptor and modulates the transcription of cytokine genes, thereby decreasing the production of inflammatory mediators such as interleukin‑1β, interleukin‑6, and tumor necrosis factor‑alpha. This dual mechanism allows the cream to address the underlying infection while simultaneously alleviating the signs and symptoms of inflammation, including erythema, edema, and pruritus.

Uses and Benefits

The therapeutic utility of Candid B Cream spans a range of common cutaneous mycoses complicated by inflammatory responses. Clinically, it is employed for:

• Distal and proximal dermatophytosis (tinea corporis) affecting the trunk, limbs or scalp
• Intertriginous candidiasis, particularly in the groin (tinea cruris), axillae, neck folds and inframammary regions
• Superficial cutaneous candidiasis in immunocompromised patients when a combined antifungal‑anti‑inflammatory approach is warranted
• Maintenance therapy to prevent recurrence after initial control of the infection

Patients experience rapid symptomatic relief, often within 48‑72 hours, as the corticosteroid component dampens the itching and redness while the antifungal clears the causative organism. The combined action also reduces the likelihood of secondary bacterial superinfection by decreasing skin breakdown and scratching. Moreover, the cream’s semi‑occlusive base facilitates deeper penetration of both actives into the stratum corneum, enhancing overall efficacy compared with monotherapy formulations.

How It Works

Pharmacodynamically, the cream provides a synergistic therapeutic effect. Clotrimazole’s fungistatic activity is concentration‑dependent; it binds to the heme group of cytochrome P450 enzymes, preventing the conversion of lanosterol to ergosterol, a critical component of the fungal membrane. This leads to membrane instability and eventual fungal cell death. Beclometasone dipropionate is a prodrug that is hydrolyzed in situ to beclometasone, a high‑affinity ligand for the intracellular glucocorticoid receptor. Activation of this receptor results in trans‑repression of NF‑κB and AP‑1 signaling pathways, diminishing the expression of pro‑inflammatory cytokines and chemokines. The net result is a rapid reduction in inflammatory signs while the antifungal component eliminates the infection source. The formulation’s vehicle contains emollients and humectants that improve skin hydration, supporting barrier repair and enhancing drug distribution.

Dosage Guidelines

For adults and children aged 2 years and older, the recommended application is a thin layer of Candid B Cream applied to the affected dermatological area twice daily, typically in the morning and before bedtime. The duration of therapy is generally 2‑4 weeks, depending on the diagnosis, extent of lesions and clinical response. In more extensive or recalcitrant infections, a healthcare professional may extend treatment up to 6 weeks, but this should only be done under medical supervision. Special considerations include:

• Pediatric patients (2‑12 years) may require a lower frequency, such as once daily, based on body surface area and tolerability.
• Patients with large surface‑area involvement (greater than 20 % of total skin) should be evaluated for systemic therapy if local treatment proves insufficient.
• If a dose is missed, the patient should apply it as soon as remembered unless it is close to the time of the next scheduled dose; in that case, the missed dose should be skipped and the regular schedule resumed.
• Application should be avoided on the eyes, lips, or mucous membranes; accidental contact should be rinsed with water.

Patients are advised to continue treatment for the full prescribed period, even if symptoms improve early, to prevent relapse and development of resistant organisms.

Side Effects

Adverse reactions are generally mild and limited to the application site. The most commonly reported side effects include:

• Transient burning, stinging or itching upon application
• Dryness or mild scaling of the treated skin
• Contact dermatitis, characterized by erythema, edema or papular eruptions

Less frequent but clinically significant effects may involve skin atrophy, telangiectasia or secondary fungal overgrowth if the product is used under occlusive dressings for prolonged periods. Systemic absorption is rare but can occur with extensive surface area use, leading to signs of corticosteroid excess such as weight gain, hypertension or hyperglycemia, particularly in pediatric patients. In the event of any severe or persistent adverse reaction, discontinuation of the product and consultation with a healthcare professional are recommended. Patients should be instructed to report any signs of allergic reaction, such as swelling of the face, lips or throat, or difficulty breathing, which require immediate medical attention.

Warnings and Precautions

Candid B Cream is intended for external use only and should not be ingested. It is contraindicated in individuals with known hypersensitivity to clotrimazole, beclometasone or any of the excipients. The product must not be applied to active viral skin lesions, such as herpes simplex or varicella, unless a physician determines that the benefits outweigh the risks. Because corticosteroids can suppress local immune defenses, prolonged use on large areas, especially in children, may increase the risk of systemic corticosteroid effects; therefore, treatment should be limited to the shortest duration necessary. The cream should be stored at room temperature, away from direct heat and moisture, and the cap should be tightly closed after each use to prevent contamination. Drug interactions are uncommon with topical use, but caution is advised when applying other topical medications to the same area, as this may alter absorption or increase the risk of irritation. Patients with immunocompromised conditions, such as HIV/AIDS or those receiving immunosuppressive therapy, should seek medical advice before initiating treatment to ensure appropriate management of potential secondary infections.

Frequently Asked Questions

Q: Can Candid B Cream be used for acne or rosacea?

A: No. This medication is formulated specifically for fungal infections accompanied by inflammation. Acne and rosacea require different therapeutic classes and should be managed under the guidance of a dermatologist.

Q: How quickly does the cream relieve itching?

A: Most users report a noticeable reduction in itching within 24‑48 hours after the first application, due to the anti‑inflammatory action of the corticosteroid component.

Q: Is it safe to apply Candid B Cream during pregnancy or while breastfeeding?

A: Topical use is generally considered low risk, but the product should only be used if a healthcare provider determines that the expected benefit justifies any potential risk. Pregnant or lactating individuals should consult their physician before use.

Q: Can the cream be used on the face or near the eyes?

A: It may be applied to facial skin only when prescribed for a facial fungal infection and under medical supervision. Contact with the eyes must be avoided; if accidental contact occurs, rinse thoroughly with water.

Q: What should I do if I accidentally swallow a small amount?

A: Ingestion of a small amount is unlikely to cause serious harm, but if a larger quantity is swallowed, seek medical attention promptly or contact a poison control center.

For further reading on the underlying conditions, consult the National Institutes of Health overview of dermatophyte infections, the U.S. Food and Drug Administration drug labeling resources, and the MedlinePlus monograph on clotrimazole/beclometasone.

Related Products

• Candid Cream (Clotrimazole)
• Glinate 60 mg (Nateglinide)
• Mignar 25 mg (Miglitol)
• Tolvasca 15 mg (Tolvaptan)
• Fenza 2% Cream (Fenticonazole)
• Tazret Forte Cream (Tazarotene)
• Tazret Gel 0.05% (Tazarotene)
• Ifin (Terbinafine)
• Ifin 250 mg (Terbinafine)
• Ifin 500 mg (Terbinafine)
• Tigi 50 mg (Tigecycline)
• Glinate (Nateglinide)